237 related articles for article (PubMed ID: 37196908)
21. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
22. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.
Xia T; Wu X; Cao M; Zhang P; Shi G; Zhang J; Lu Z; Wu P; Cai B; Miao Y; Jiang K
Pathol Res Pract; 2019 Nov; 215(11):152666. PubMed ID: 31606241
[TBL] [Abstract][Full Text] [Related]
23. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
24. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
Xu J; Chen Q; Tian K; Liang R; Chen T; Gong A; Mathy NW; Yu T; Chen X
Oncol Rep; 2020 Sep; 44(3):973-986. PubMed ID: 32705223
[TBL] [Abstract][Full Text] [Related]
25. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
[TBL] [Abstract][Full Text] [Related]
26. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
27. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
[TBL] [Abstract][Full Text] [Related]
28. Reduced N6-Methyladenosine Mediated by METTL3 Acetylation Promotes MTF1 Expression and Hepatocellular Carcinoma Cell Growth.
Yang Y; Qian Cai Q; Sheng Fu L; Wei Dong Y; Fan F; Zhong Wu X
Chem Biodivers; 2022 Nov; 19(11):e202200333. PubMed ID: 36149370
[TBL] [Abstract][Full Text] [Related]
29. HBXIP promotes gastric cancer
Yang Z; Jiang X; Li D; Jiang X
Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
[TBL] [Abstract][Full Text] [Related]
30. The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells.
Taketo K; Konno M; Asai A; Koseki J; Toratani M; Satoh T; Doki Y; Mori M; Ishii H; Ogawa K
Int J Oncol; 2018 Feb; 52(2):621-629. PubMed ID: 29345285
[TBL] [Abstract][Full Text] [Related]
31. Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis.
Zhou Y; Jiang R; Jiang Y; Fu Y; Manafhan Y; Zhu J; Jia E
Cells; 2022 Sep; 11(19):. PubMed ID: 36230944
[TBL] [Abstract][Full Text] [Related]
32. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
[TBL] [Abstract][Full Text] [Related]
33. METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury.
He X; Zhang J; Guo Y; Yang X; Huang Y; Hao D
Mol Neurobiol; 2023 May; 60(5):2413-2425. PubMed ID: 36656457
[TBL] [Abstract][Full Text] [Related]
34. METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.
Yu T; Liu J; Wang Y; Chen W; Liu Z; Zhu L; Zhu W
Biochem Biophys Res Commun; 2022 Jul; 614():9-16. PubMed ID: 35567945
[TBL] [Abstract][Full Text] [Related]
35. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
36. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
[TBL] [Abstract][Full Text] [Related]
37. The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.
Xie J; Ba J; Zhang M; Wan Y; Jin Z; Yao Y
J BUON; 2021; 26(2):444-449. PubMed ID: 34076991
[TBL] [Abstract][Full Text] [Related]
38. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
[TBL] [Abstract][Full Text] [Related]
39. METTL3 Promotes Osteosarcoma Metastasis via an m6A-dependent Epigenetic Activity of CBX4.
Huo XS; Lu D; Chen DG; Ye M; Wang XW; Shang FS
Front Biosci (Landmark Ed); 2024 Mar; 29(3):120. PubMed ID: 38538251
[TBL] [Abstract][Full Text] [Related]
40. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
Huang X; Yang Z; Li Y; Long X
Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]